A Comprehensive Picture of Extracellular Vesicles and Their Contents. Molecular Transfer to Cancer Cells.
biogenesis
cancer
clinical implications
extracellular vesicles
function
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
27 Jan 2020
27 Jan 2020
Historique:
received:
20
11
2019
revised:
09
01
2020
accepted:
15
01
2020
entrez:
5
2
2020
pubmed:
6
2
2020
medline:
6
2
2020
Statut:
epublish
Résumé
Critical processes such as growth, invasion, and metastasis of cancer cells are sustained via bidirectional cell-to-cell communication in tissue complex environments. Such communication involves the secretion of soluble factors by stromal cells and/or cancer cells within the tumor microenvironment (TME). Both stromal and cancer cells have been shown to export bilayer nanoparticles: encapsulated regulatory molecules that contribute to cell-to-cell communication. These nanoparticles are known as extracellular vesicles (EVs) being classified into exosomes, microvesicles, and apoptotic bodies. EVs carry a vast repertoire of molecules such as oncoproteins and oncopeptides, DNA fragments from parental to target cells, RNA species (mRNAs, microRNAs, and long non-coding RNA), and lipids, initiating phenotypic changes in TME. According to their specific cargo, EVs have crucial roles in several early and late processes associated with tumor development and metastasis. Emerging evidence suggests that EVs are being investigated for their implication in early cancer detection, monitoring cancer progression and chemotherapeutic response, and more relevant, the development of novel targeted therapeutics. In this study, we provide a comprehensive understanding of the biophysical properties and physiological functions of EVs, their implications in TME, and highlight the applicability of EVs for the development of cancer diagnostics and therapeutics.
Identifiants
pubmed: 32012717
pii: cancers12020298
doi: 10.3390/cancers12020298
pmc: PMC7072213
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Exp Mol Med. 2017 Jan 20;49(1):e285
pubmed: 28104913
Nat Cell Biol. 2008 Dec;10(12):1470-6
pubmed: 19011622
Cell Biosci. 2019 Feb 15;9:19
pubmed: 30815248
Mol Ther. 2011 Feb;19(2):395-9
pubmed: 21102562
Traffic. 2018 May;19(5):319-327
pubmed: 29479795
Cell. 2012 Dec 21;151(7):1542-56
pubmed: 23260141
Am J Pathol. 2010 May;176(5):2490-9
pubmed: 20348242
Cancer Sci. 2018 Mar;109(3):629-641
pubmed: 29285843
Biomed Pharmacother. 2019 Mar;111:338-346
pubmed: 30590322
EBioMedicine. 2019 Mar;41:225-235
pubmed: 30737083
Pharmaceutics. 2018 Nov 06;10(4):
pubmed: 30404188
Cells. 2012 Dec 05;1(4):1156-67
pubmed: 24710548
Nat Rev Cancer. 2017 Jun;17(6):367-380
pubmed: 28386091
J Proteome Res. 2008 Dec;7(12):5157-66
pubmed: 19367702
Adv Virol. 2009 Jan 1;2009:6239691-6239699
pubmed: 19865606
J Extracell Vesicles. 2013 Mar 05;2:
pubmed: 24009895
Nat Cell Biol. 2010 Jan;12(1):19-30; sup pp 1-13
pubmed: 19966785
Am J Physiol Lung Cell Mol Physiol. 2004 Jan;286(1):L49-67
pubmed: 14656699
Oncogene. 2017 Mar 30;36(13):1770-1778
pubmed: 27669441
Biomed Res Int. 2014;2014:619829
pubmed: 24575409
Drug Des Devel Ther. 2017 Sep 27;11:2871-2890
pubmed: 29033548
Curr Biol. 2018 Apr 23;28(8):R435-R444
pubmed: 29689228
J Extracell Vesicles. 2014 Aug 04;3:
pubmed: 25143819
Biochem Soc Trans. 2013 Feb 1;41(1):277-82
pubmed: 23356297
Int J Cancer. 2005 Apr 20;114(4):613-22
pubmed: 15609328
J Cell Biol. 2016 Feb 29;212(5):499-513
pubmed: 26929449
J Biol Chem. 2003 May 30;278(22):20083-90
pubmed: 12639953
Genome Res. 2017 Jul;27(7):1112-1125
pubmed: 28411194
PLoS One. 2012;7(10):e47365
pubmed: 23077602
Int J Nanomedicine. 2017 Jun 26;12:4593-4606
pubmed: 28721037
Cell. 2005 May 6;121(3):335-48
pubmed: 15882617
Platelets. 2004 Mar;15(2):109-15
pubmed: 15154603
Nat Commun. 2013;4:2712
pubmed: 24231649
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):E3234-42
pubmed: 24938788
Mol Ther. 2011 Sep;19(9):1656-66
pubmed: 21750535
Mol Ther Nucleic Acids. 2013 Oct 01;2:e126
pubmed: 24084846
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
J Transl Med. 2005 Feb 21;3(1):9
pubmed: 15723705
Cell. 2014 Apr 10;157(2):407-419
pubmed: 24725407
Cell. 2015 May 7;161(4):774-89
pubmed: 25957685
Biomaterials. 2016 May;89:56-66
pubmed: 26950165
Cell Commun Signal. 2015 Feb 03;13:8
pubmed: 25644060
J Immunol. 2004 Feb 15;172(4):2126-36
pubmed: 14764678
Cancer Cell. 2010 Feb 17;17(2):135-47
pubmed: 20138012
Blood. 2004 Nov 1;104(9):2761-6
pubmed: 15242875
J Exp Clin Cancer Res. 2018 Jul 9;37(1):143
pubmed: 29986759
Oncotarget. 2017 May 30;8(22):36137-36148
pubmed: 28410224
Cancer Cell Int. 2017 Jun 6;17:62
pubmed: 28592924
Cancer Res. 2006 May 1;66(9):4795-801
pubmed: 16651434
PLoS One. 2012;7(12):e50999
pubmed: 23251413
AAPS J. 2017 Mar;19(2):475-486
pubmed: 27882487
Front Immunol. 2018 May 23;9:1111
pubmed: 29875772
Cancer Sci. 2018 Aug;109(8):2364-2374
pubmed: 29908100
Clin Exp Metastasis. 2017 Apr;34(3-4):273-289
pubmed: 28317069
Sci Rep. 2014 Feb 07;4:4031
pubmed: 24504253
Pediatr Nephrol. 2019 Jan;34(1):11-30
pubmed: 29181712
Nat Med. 2001 Mar;7(3):297-303
pubmed: 11231627
PLoS One. 2015 May 04;10(5):e0125625
pubmed: 25938772
Science. 2008 Feb 29;319(5867):1244-7
pubmed: 18309083
Int J Cancer. 2018 Mar 15;142(6):1086-1092
pubmed: 28983919
PeerJ. 2018 May 29;6:e4763
pubmed: 29868251
Small GTPases. 2012 Oct-Dec;3(4):219-24
pubmed: 22906997
Prog Lipid Res. 2017 Apr;66:30-41
pubmed: 28342835
Nat Commun. 2016 Mar 29;7:11150
pubmed: 27021436
Front Cell Dev Biol. 2018 Oct 02;6:95
pubmed: 30333973
Nat Rev Clin Oncol. 2018 Oct;15(10):617-638
pubmed: 29795272
FASEB J. 2014 Aug;28(8):3703-19
pubmed: 24812088
Pain. 2014 Aug;155(8):1527-39
pubmed: 24792623
Front Cell Dev Biol. 2018 Feb 20;6:18
pubmed: 29515996
Oncogene. 2019 Mar;38(11):1951-1965
pubmed: 30390075
Br J Haematol. 1967 May;13(3):269-88
pubmed: 6025241
Biomater Sci. 2017 Dec 19;6(1):60-78
pubmed: 29184934
Nat Rev Immunol. 2011 Oct 25;11(11):750-61
pubmed: 22025054
Semin Cell Dev Biol. 2017 Jul;67:48-55
pubmed: 28104520
Nat Med. 1998 May;4(5):594-600
pubmed: 9585234
Int J Mol Sci. 2016 Aug 09;17(8):
pubmed: 27517914
Mol Neurobiol. 2016 Mar;53(2):818-834
pubmed: 25502465
Int J Cancer. 2016 Feb 15;138(4):939-48
pubmed: 26341361
J Biol Chem. 1987 Jul 5;262(19):9412-20
pubmed: 3597417
Cell Biol Int. 2016 Oct;40(10):1050-61
pubmed: 27435911
Int J Mol Med. 2008 Jan;21(1):63-7
pubmed: 18097617
Elife. 2014 May 30;3:
pubmed: 24878737
Int J Nanomedicine. 2014 Jul 22;9:3465-79
pubmed: 25092977
J Clin Invest. 2016 Apr 1;126(4):1224-32
pubmed: 27035813
Cancer Res. 2010 Dec 1;70(23):9621-30
pubmed: 21098712
Blood. 2013 Feb 7;121(6):984-95
pubmed: 23144169
Nat Commun. 2017 Jan 09;8:14041
pubmed: 28067230
J Immunol. 2002 Apr 1;168(7):3235-41
pubmed: 11907077
J Extracell Vesicles. 2015 Jun 19;4:27522
pubmed: 26095380
J Biol Chem. 2014 Jan 17;289(3):1303-12
pubmed: 24297178
Nat Commun. 2012;3:1282
pubmed: 23250412
J Leukoc Biol. 2014 May;95(5):817-825
pubmed: 24379213
Dig Liver Dis. 2009 Dec;41(12):875-80
pubmed: 19473897
PLoS One. 2014 Apr 16;9(4):e95240
pubmed: 24740415
Nat Commun. 2015 Jun 15;6:7439
pubmed: 26074490
Cell Res. 2014 Jun;24(6):766-9
pubmed: 24710597
Genes Dev. 2012 Jun 15;26(12):1287-99
pubmed: 22713869
Nature. 2011 May 19;473(7347):298-307
pubmed: 21593862
Mol Neurodegener. 2017 Jan 13;12(1):5
pubmed: 28086931
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
J Biol Chem. 2014 Feb 14;289(7):3869-75
pubmed: 24398677
Trends Cell Biol. 2015 Jun;25(6):364-72
pubmed: 25683921
Parasitology. 1990 Apr;100 Pt 2:337-43
pubmed: 2345666
Clin Pharmacol Ther. 2011 Apr;89(4):491-502
pubmed: 21368752
Onco Targets Ther. 2018 Mar 19;11:1529-1541
pubmed: 29593419
Onco Targets Ther. 2018 Sep 12;11:5753-5762
pubmed: 30254468
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):E2110-6
pubmed: 22753494
Cancer Cell. 2016 Aug 8;30(2):243-256
pubmed: 27505671
FEBS Lett. 2016 Dec;590(23):4263-4274
pubmed: 27714787
Int J Mol Sci. 2014 Jan 20;15(1):1392-401
pubmed: 24447928
Noncoding RNA. 2019 Mar 21;5(1):
pubmed: 30901915
J Extracell Vesicles. 2013 Sep 12;2:
pubmed: 24223256
Annu Rev Cell Dev Biol. 2014;30:111-39
pubmed: 25000995
Biochem Soc Trans. 2010 Dec;38(6):1413-6
pubmed: 21118098
Cell Death Differ. 2010 Nov;17(11):1665-71
pubmed: 20706273
J Immunol. 2010 Nov 1;185(9):5236-46
pubmed: 20921526
Nat Med. 2013 Feb;19(2):227-31
pubmed: 23353556
Cancer Cell. 2014 Nov 10;26(5):707-21
pubmed: 25446899
Cell. 2017 Jul 13;170(2):352-366.e13
pubmed: 28709002
World J Gastroenterol. 2015 May 28;21(20):6215-28
pubmed: 26034356
J Clin Invest. 2016 Apr 1;126(4):1139-43
pubmed: 27035805
Nat Commun. 2017 Apr 10;8:15016
pubmed: 28393839
J Immunol. 2007 Jun 1;178(11):6867-75
pubmed: 17513735
Front Oncol. 2019 Mar 06;9:125
pubmed: 30895170
Nanomedicine. 2018 Jan;14(1):195-204
pubmed: 28982587
J Mol Cell Biol. 2013 Aug;5(4):214-26
pubmed: 23918283
J Neurooncol. 2013 May;113(1):1-11
pubmed: 23456661
Oncoimmunology. 2013 Jan 1;2(1):e22337
pubmed: 23482694
Mol Med Rep. 2014 Jan;9(1):125-31
pubmed: 24173626
J Cell Sci. 2008 Feb 1;121(Pt 3):290-7
pubmed: 18198188
J Cell Biol. 2015 Oct 12;211(1):27-37
pubmed: 26459596
J Immunol. 2012 Sep 15;189(6):2833-42
pubmed: 22904309
Sci Rep. 2015 Oct 13;5:14748
pubmed: 26458510
J Cell Biol. 1985 Sep;101(3):942-8
pubmed: 2993317
J Nanobiotechnology. 2018 Oct 16;16(1):81
pubmed: 30326899
Cancer Res. 2011 Aug 1;71(15):5346-56
pubmed: 21670082
Biochem Soc Trans. 2019 Apr 30;47(2):725-732
pubmed: 30850425
Mol Ther. 2010 Sep;18(9):1606-14
pubmed: 20571541
Anticancer Res. 2010 May;30(5):1707-12
pubmed: 20592365
Mol Ther Nucleic Acids. 2019 Jun 7;16:407-418
pubmed: 31022607
Mol Cell Proteomics. 2012 Aug;11(8):230-43
pubmed: 22345510
Blood. 2013 Nov 28;122(23):3808-17
pubmed: 23954892
BMC Cancer. 2011 Mar 27;11:108
pubmed: 21439085
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Mol Cancer. 2015 Aug 14;14:155
pubmed: 26272696
Cell Death Differ. 2015 Jan;22(1):34-45
pubmed: 25236394
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
Nanomedicine. 2016 Apr;12(3):655-664
pubmed: 26586551
Mol Cancer Res. 2017 Dec;15(12):1656-1666
pubmed: 28923840
J Cancer Res Clin Oncol. 2017 Jun;143(6):991-1004
pubmed: 28285404
J Control Release. 2015 Dec 28;220(Pt B):727-37
pubmed: 26390807
Sci Rep. 2016 Dec 12;6:38541
pubmed: 27941871
Proc Natl Acad Sci U S A. 2011 May 24;108(21):8809-14
pubmed: 21555566
J Exp Clin Cancer Res. 2019 Jul 18;38(1):317
pubmed: 31319863
Immunol Res. 2018 Jun;66(3):313-322
pubmed: 29804198
Cancer Res. 2009 Jul 1;69(13):5601-9
pubmed: 19549916
J Natl Cancer Inst. 2013 Mar 20;105(6):371-2
pubmed: 23457207
Trends Mol Med. 2015 Oct;21(10):595-608
pubmed: 26432017
Drug Resist Updat. 2019 Jul;45:1-12
pubmed: 31369918
Nat Commun. 2018 Jan 30;9(1):435
pubmed: 29382847
Acta Pharm Sin B. 2016 Jul;6(4):287-96
pubmed: 27471669
Am J Transl Res. 2016 May 15;8(5):2432-7
pubmed: 27347352
Front Immunol. 2018 Jul 03;9:1534
pubmed: 30018618
PLoS One. 2013 Apr 12;8(4):e61515
pubmed: 23593486
Cancer Cell. 2017 Nov 13;32(5):654-668.e5
pubmed: 29136508
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9066-E9075
pubmed: 29073103
PLoS One. 2014 Apr 04;9(4):e92921
pubmed: 24705249
Cell. 2014 Jul 31;158(3):564-78
pubmed: 25083868
Oncotarget. 2015 May 10;6(13):11327-41
pubmed: 25857301
J Cancer. 2018 Aug 6;9(17):3084-3092
pubmed: 30210631
Biol Pharm Bull. 2018;41(6):835-842
pubmed: 29863072
Mol Cancer. 2019 Mar 1;18(1):32
pubmed: 30823926
Tumour Biol. 2015 Mar;36(3):2007-12
pubmed: 25391424
Exp Cell Res. 2006 Jan 1;312(1):5-15
pubmed: 16259978
Stem Cells Dev. 2016 Sep 1;25(17):1290-8
pubmed: 27465939
Nat Rev Cancer. 2012 Mar 15;12(4):298-306
pubmed: 22419253
Mol Cancer. 2019 Mar 30;18(1):59
pubmed: 30925927
Nat Rev Microbiol. 2007 Dec;5(12):912-6
pubmed: 17982468
Mol Cancer Ther. 2005 Oct;4(10):1595-604
pubmed: 16227410
Mol Ther. 2017 Jul 5;25(7):1665-1675
pubmed: 28284981
Int J Cancer. 2009 Sep 1;125(5):1016-26
pubmed: 19405120
Blood. 2015 Aug 27;126(9):1106-17
pubmed: 26100252
J Cell Biol. 2016 Apr 25;213(2):173-84
pubmed: 27114500
Front Immunol. 2018 Jun 28;9:1486
pubmed: 30002658
Nat Commun. 2011 Feb 01;2:180
pubmed: 21285958
J Hematol Oncol. 2015 Oct 29;8:122
pubmed: 26514126
Small GTPases. 2017 Oct 2;8(4):220-232
pubmed: 27494381
Front Immunol. 2017 Sep 22;8:1174
pubmed: 29018443
Nat Rev Immunol. 2009 Aug;9(8):581-93
pubmed: 19498381
Biomaterials. 2014 Feb;35(7):2383-90
pubmed: 24345736
Mol Cell Proteomics. 2018 Mar;17(3):495-515
pubmed: 29242380
Oncogene. 2012 Nov 8;31(45):4740-9
pubmed: 22266864
Clin Cancer Res. 2016 Jul 15;22(14):3499-512
pubmed: 26944067
J Gastrointest Oncol. 2011 Dec;2(4):215-22
pubmed: 22811855
J Cell Physiol. 2012 Feb;227(2):658-67
pubmed: 21465472
PLoS One. 2013 Jul 29;8(7):e69034
pubmed: 23922679
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Cancer Res. 2003 Aug 1;63(15):4331-7
pubmed: 12907600
Mol Cancer. 2019 Mar 30;18(1):52
pubmed: 30925917
Cell. 2014 Oct 23;159(3):499-513
pubmed: 25417103
Nature. 2015 Jul 9;523(7559):177-82
pubmed: 26106858
Trends Biochem Sci. 2017 Jan;42(1):42-56
pubmed: 27669649
Curr Opin Cell Biol. 2009 Aug;21(4):575-81
pubmed: 19442504
J Control Release. 2017 Feb 10;247:1-18
pubmed: 28024915
Nat Rev Clin Oncol. 2017 Sep;14(9):531-548
pubmed: 28252003
Blood. 2016 Apr 21;127(16):1976-86
pubmed: 26903549
Cancer Sci. 2015 Jan;106(1):60-8
pubmed: 25457412
Elife. 2016 Feb 27;5:e10250
pubmed: 26920219
Am J Pathol. 2012 Nov;181(5):1573-84
pubmed: 23022210
Traffic. 2010 May;11(5):675-87
pubmed: 20136776
J Cell Physiol. 2020 Feb;235(2):691-705
pubmed: 31328284
Crit Rev Biochem Mol Biol. 2018 Oct;53(5):564-577
pubmed: 30247075
PLoS One. 2017 Jan 20;12(1):e0169932
pubmed: 28107450
J Exp Clin Cancer Res. 2018 Sep 14;37(1):226
pubmed: 30217217
J Exp Med. 1996 Mar 1;183(3):1161-72
pubmed: 8642258
ScientificWorldJournal. 2015;2015:657086
pubmed: 25695100
Blood. 1999 Jun 1;93(11):3956-63
pubmed: 10339505
PLoS One. 2014 Oct 17;9(10):e110314
pubmed: 25330373
J Extracell Vesicles. 2015 Jun 19;4:26192
pubmed: 26095379
Front Immunol. 2018 Apr 30;9:738
pubmed: 29760691
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
J Control Release. 2014 Oct 28;192:262-70
pubmed: 25084218
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15336-41
pubmed: 21873242
Leukemia. 2009 Sep;23(9):1643-9
pubmed: 19369960
Mol Ther. 2013 Jan;21(1):101-8
pubmed: 22910294
Int J Mol Sci. 2016 Feb 06;17(2):175
pubmed: 26861306
Oncotarget. 2016 Sep 13;7(37):59173-59188
pubmed: 27385095
Biochem Biophys Res Commun. 2014 Mar 7;445(2):381-7
pubmed: 24525123
Genes Chromosomes Cancer. 2012 Apr;51(4):409-18
pubmed: 22420032
Oncogene. 2013 May 30;32(22):2747-55
pubmed: 22797057
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123
J Cell Biol. 1999 Nov 1;147(3):599-610
pubmed: 10545503
Neoplasia. 2016 Jan;18(1):25-32
pubmed: 26806349
J Immunol. 2001 Jun 15;166(12):7309-18
pubmed: 11390481
Nat Rev Cancer. 2017 May;17(5):302-317
pubmed: 28303905
J Exp Clin Cancer Res. 2019 May 17;38(1):201
pubmed: 31101062
Front Pharmacol. 2017 Jan 12;7:533
pubmed: 28127287
Cancer Res. 2019 May 15;79(10):2462-2465
pubmed: 31043377
Oncologist. 2003;8(5):411-24
pubmed: 14530494
Cell Cycle. 2013 Nov 15;12(22):3526-36
pubmed: 24091630
Oncol Rep. 2012 Nov;28(5):1551-8
pubmed: 22895844
Cell Res. 2016 Jun;26(6):713-27
pubmed: 27167569
EMBO Rep. 2014 Dec;15(12):1243-53
pubmed: 25381661
Clin Transl Med. 2017 Dec 13;6(1):45
pubmed: 29238879
Cancer Lett. 2013 Jul 10;335(1):201-4
pubmed: 23419525
Mol Ther. 2013 Jan;21(1):185-91
pubmed: 23032975
Pharm Res. 2015 Jun;32(6):2003-14
pubmed: 25609010
Int J Nanomedicine. 2017 May 15;12:3721-3733
pubmed: 28553110
Front Mol Biosci. 2017 Jul 18;4:50
pubmed: 28770210
J Enzyme Inhib Med Chem. 2017 Dec;32(1):648-657
pubmed: 28262028
Nat Rev Urol. 2014 Dec;11(12):688-701
pubmed: 25403245
Tumour Biol. 2016 Apr;37(4):5247-56
pubmed: 26555545
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394
Semin Cell Dev Biol. 2015 Apr;40:41-51
pubmed: 25721812
Traffic. 2011 Dec;12(12):1659-68
pubmed: 21645191
J Natl Cancer Inst. 2001 Feb 21;93(4):266-76
pubmed: 11181773